Form 4 holding
Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 161,054
- Estimated value
- $9,360
- Report date
- 26 Feb 2026
- Price
- $0.2280
- Ownership
- Direct
Irit Arbel - Director at BRAINSTORM CELL THERAPEUTICS INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BCLI on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Irit Arbel since 25 Jun 2025
Reported holdings for Irit Arbel in BRAINSTORM CELL THERAPEUTICS INC.
Transaction history for Irit Arbel in BRAINSTORM CELL THERAPEUTICS INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.